Neurotoxins Stocks List

Neurotoxins Stocks Recent News

Date Stock Title
May 10 RVNC Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
May 10 RVNC Revance Therapeutics Reports Q1 2024 Financial Results: Revenue Growth Amidst Rising Operating ...
May 10 EOLS Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
May 10 RVNC Revance Therapeutics Inc. (RVNC) Q1 2024 Earnings Call Transcript
May 9 RVNC Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
May 9 RVNC Revance Therapeutics GAAP EPS of -$0.58, revenue of $51.94M
May 9 RVNC Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
May 9 RVNC Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia
May 9 EOLS Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 8 RVNC Revance Therapeutics Q1 2024 Earnings Preview
May 8 EOLS Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript
May 8 EOLS Q1 2024 Evolus Inc Earnings Call
May 8 EOLS Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...
May 8 EOLS Evolus, Inc. (EOLS) Q1 2024 Earnings Call Transcript
May 7 EOLS Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
May 7 EOLS Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth
May 7 EOLS Evolus GAAP EPS of -$0.22 in-line, revenue of $59.33M beats by $2.01M
May 7 EOLS Evolus Reports First Quarter 2024 Results and Provides Business Update
May 6 EOLS Evolus Q1 2024 Earnings Preview
Neurotoxins

Neurotoxins are toxins that are poisonous or destructive to nerve tissue (causing neurotoxicity). Neurotoxins are an extensive class of exogenous chemical neurological insults that can adversely affect function in both developing and mature nervous tissue. The term can also be used to classify endogenous compounds, which, when abnormally contacted, can prove neurologically toxic. Though neurotoxins are often neurologically destructive, their ability to specifically target neural components is important in the study of nervous systems. Common examples of neurotoxins include lead, ethanol (drinking alcohol), manganese glutamate, nitric oxide, botulinum toxin (e.g. Botox), tetanus toxin, and tetrodotoxin. Some substances such as nitric oxide and glutamate are in fact essential for proper function of the body and only exert neurotoxic effects at excessive concentrations.
Neurotoxins inhibit neuron control over ion concentrations across the cell membrane, or communication between neurons across a synapse. Local pathology of neurotoxin exposure often includes neuron excitotoxicity or apoptosis but can also include glial cell damage. Macroscopic manifestations of neurotoxin exposure can include widespread central nervous system damage such as intellectual disability, persistent memory impairments, epilepsy, and dementia. Additionally, neurotoxin-mediated peripheral nervous system damage such as neuropathy or myopathy is common. Support has been shown for a number of treatments aimed at attenuating neurotoxin-mediated injury, such as antioxidant and antitoxin administration.

Browse All Tags